Abstract

Many barriers prevent individuals with substance use disorders from receiving hepatitis C virus (HCV) treatment. This study describes 96 patients with active HCV treated in an opioid use disorder bridge clinic model. Of 33 patients who initiated treatment, 25 patients completed treatment, and 13 patients achieved sustained virologic response.

Details

Title
Hepatitis C Cascade of Care in a Multidisciplinary Substance Use Bridge Clinic Model in Tennessee
Author
Chirunomula, Samantha 1 ; Muscarella, Anahit 2   VIAFID ORCID Logo  ; Whelchel, Kristen 2   VIAFID ORCID Logo  ; Gispen, Fiona 3 ; Marcovitz, David 4 ; White, Katie 5 ; Chastain, Cody 5   VIAFID ORCID Logo 

1  Division of Infectious Diseases, Department of Medicine, University of Illinois at Chicago , Chicago, Illinois , USA 
2  Department of Pharmacy, Vanderbilt Specialty Pharmacy, Vanderbilt University Medical Center , Nashville, Tennessee , USA 
3  Division of Infectious Diseases, Weill Cornell Medicine , New York, New York , USA 
4  Division of Addiction Psychiatry, Department of Medicine, Vanderbilt University Medical Center , Nashville, Tennessee , USA 
5  Division of Infectious Diseases, Department of Medicine, Vanderbilt University Medical Center , Nashville, Tennessee , USA 
Publication year
2024
Publication date
May 2024
Publisher
Oxford University Press
e-ISSN
23288957
Source type
Scholarly Journal
Language of publication
English
DOI
https://doi.org/10.1093/ofid/ofae205
ProQuest document ID
3170970750
Copyright
© The Author(s) 2024. Published by Oxford University Press on behalf of Infectious Diseases Society of America. This work is published under https://creativecommons.org/licenses/by-nc-nd/4.0/ (the “License”). Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License.